Navigation Links
Entest BioMedical Inc. Adds Former National Cancer Institute Researcher to Scientific Advisory Board With Focus on Stem Cell Cancer Patient Therapies
Date:6/8/2009

SAN DIEGO, June 8 /PRNewswire-FirstCall/ -- Dr. Steven Josephs, Ph.D., a former National Cancer Institute (NCI) researcher, has joined Entest BioMedical Inc.'s (www.entestbio.com) Science Advisory Board where he will focus on expanding the company's stem cell cancer research. Dr. Josephs' NCI research involved studies of the human T-cell leukemia virus, HIV and Human Herpervirus-6 genetic characterization. Josephs also worked for Baxter Healthcare and GenStar Therapeutics where he focused on the cellular and molecular biology of gene therapy for hemophilia. Entest BioMedical Inc. is a wholly-owned subsidiary of San Diego-based Bio-Matrix Scientific Group Inc. (OTC Bulletin Board: BMSN; www.BMSN.us).

According to David Koos, Chairman and CEO of both Entest BioMedical Inc. and Bio-Matrix Scientific Group Inc., "Dr. Josephs' extensive cancer research background adds strength to our growing Scientific Advisory Board. His insight into potential stem cell therapies for cancer patients will help expedite Entest BioMedical's goal of providing innovative stem cell transplantation therapies and services including autologous and allogenic peripheral blood or bone marrow transplantation.

Dr. Feng Lin, Director of Research for Entest BioMedical and Bio-Matrix Scientific Group, also applauded the addition of Dr. Josephs' to the Science Advisory Board. "Dr. Josephs joins our life science team at exactly the right time," said Lin. "We're currently interested in differentiating hematopoietic stem cells into immune cells especially T-cells. Dr. Josephs will work with us on our research goal of generating a new population of immune cells from a patient's own stem cells to reactivate the patient's immune system. This strategy represents a novel and effective immunotherapy especially for cancer patients and HIV patients who
'/>"/>

SOURCE Bio-Matrix Scientific Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Bio-Matrix Scientific Group and Entest BioMedical Sign Contract With UCLA Researcher to Develop Gestational Diabetes Screening Test
2. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
3. Response Biomedical Closes $12.65 million Unit Offering
4. Garth Fisher, M.D., F.A.C.S., World Renowned Plastic Surgeon and Co-Founder Of CellCeuticals(R) Biomedical Skin Treatments Revealed On E!s Keeping Up With The Kardashians as the Surgeon Behind Bruce Jenners New Face
5. Response Biomedical Announces Proposed Unit Offering
6. Dr. Abbott J. Krieger Joins Avery Biomedical Devices, Inc. as Chief Clinical Liaison
7. Response Biomedical Corporation Delivers Record Preliminary Revenues in First Quarter
8. BioMedical Technology Solutions, Inc. a Division of BioMedical Technology Solutions Holdings, Inc. Symbol (BMTL) OTCBB Receives Frost & Sullivans Product Innovation of the Year Award
9. Foundation for Biomedical Research Announces Michael E. DeBakey Journalism Awards
10. Response Biomedical Corporation Reports 2008 Financial Results
11. Advance Internet Launches HireBioMedical.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... Children who have emergency surgery on weekends are ... death than those who have weekday surgeries, according ... Hopkins researchers noted that the risk of death ... nearly 440,000 simple emergency surgeries that children across ... The surgeries are considered generally safe and ...
(Date:7/11/2014)... According to a new market research ... Communication Technology (ZigBee, Z-Wave, Bluetooth, Wi-Fi, NFC, RFID), Application ... Transportation, Agriculture) & Geography - Global Trends & Forecasts ... Things market was worth $1029.5 Billion in 2013, and ... an estimated CAGR of 4.08% from 2014 to 2020. ...
(Date:7/11/2014)... Miriam Hospital have found that people with mobility ... of smoking than those without mobility impairments. Additionally, ... attempt quitting than those without mobility impairments, and ... this population. The study and its findings are ... American Journal of Public Health . ...
(Date:7/11/2014)... HealthDay Reporter THURSDAY, July ... children from the worldwide scourge of dengue fever was somewhat ... vaccine only prevented dengue fever in 56 percent of the ... it protected more than 88 percent of them from severe ... hospitalization, and sometimes death. "This vaccine has already proven ...
(Date:7/11/2014)... 2014 Last month Watkins Insurance Group ... joins the agency as a specialist in insurance and ... a Bachelor’s Degree in Business Administration from Texas State ... will manage everything from performance and payment bonds, license ... specialized needs for those in the asphalt supplier industry. ...
Breaking Medicine News(10 mins):Health News:Emergency Surgeries on Weekends Riskier for Kids: Study 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Internet of Things Technology & Application Market Worth $1423.09 Billion by 2020 – New Report by MarketsandMarkets 4Health News:Miriam Hospital study examines smoking prevalence 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3
... Could be targets for new treatments, researchers say , FRIDAY, ... genetic variants associated with high blood pressure in black Americans ... treat this major risk factor for heart disease and stroke. ... of PLoS Genetics , is one of a series ...
... , , , PLAINVIEW, N.Y., ... that its 2009 community outreach program has already provided more than ... Free services, including vision screenings, eye exams and eyeglasses have been ... , "We bring our ,Focus on America, ...
... ... Diprivan (Propofol) abuse , the Farley Center at Williamsburg Place, one of the nation,s leading ... ... -- In response to the recent media attention on Diprivan (Propofol) abuse , the ...
... WORCESTER, Mass., July 17 The Hanover Insurance Group (NYSE: ... today announced the availability of a new product offering that can extend ... , , (Logo: ... The coverage is more important than ever as the population of ...
... , , , WINSTON-SALEM, N.C., ... vice president for finance and chief financial officer of Wake Forest ... the Medical Center reorganization that began two years ago. He began ... CEO of the Medical Center. , , ...
... , , SKILLMAN, N.J., July ... technologies for community and hospital care, announced today it received first ... Advertising Effectiveness Awards for its Flexi-Seal((R) )Fecal Management System (FMS). ... Flexi-Seal((R)) FMS, a temporary containment device for patients with acute fecal ...
Cached Medicine News:Health News:Five Hypertension Genes Found in Black Americans 2Health News:Five Hypertension Genes Found in Black Americans 3Health News:Davis Vision Provides More Than $200,000 in Free Vision Care Services 2Health News:Davis Vision Provides More Than $200,000 in Free Vision Care Services 3Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 2Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 3Health News:Omar S. Manejwala, MD Speaks Out Nationally on Diprivan/Propofol Abuse 4Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 2Health News:The Hanover Launches New Insurance Option to Protect Family Members in Assisted Living Facilities 3Health News:Wake Forest Baptist Medical Center Names Chadwick CFO 2Health News:Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award 2Health News:Flexi-Seal(R) Fecal Management System Receives 2008 Critical Care Nurse Advertising Effectiveness Award 3
(Date:7/11/2014)... 11, 2014 According to a ... Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization Systems) ... Forecast, 2013-2019" the global endoscopy devices market was valued ... to grow at a CAGR of 6.8% from 2013 ... 36.9 billion in 2019. Browse the full ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: